Canagliflozin
A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
Year introduced: 2016 (2014)
PubMed search builder options
Subheadings:
Tree Number(s): D02.886.778.075, D03.383.903.075, D09.408.348.113
MeSH Unique ID: D000068896
Registry Number: 0SAC974Z85
Entry Terms:
- Invokana
- Canagliflozin, Anhydrous
- 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973
- Canagliflozin Hemihydrate
Pharmacologic Action: